E-LIB Suche - Ergebnisse für: Burge, R.

1

PBI12 Healthcare Resource Utilization and Costs in Patients..:

Curtis, J.R. ; Grabner, M. ; Burge, R....
Value in Health. 24 (2021) - p. S16 , 2021

Link: https://doi.org/10.1016/..

2

Clinical outcomes at 1 year in early Psoriasis Area and Sev..:

Rosmarin, D. ; Smith, S. ; Shrom, D....
Skin Health and Disease. 1 (2021) 3 - p. , 2021

Link: https://doi.org/10.1002/..

3

PBI17 Comparison of Switching Patterns Among Patients with ..:

Blauvelt, A. ; Shi, N. ; Somani, N....
Value in Health. 24 (2021) - p. S17-S18 , 2021

Link: https://doi.org/10.1016/..

4

Efficacious psoriasis treatment improves patients' work pro..:

Wu, J.J. ; Lin, C.‐Y. ; Goldblum, O....
Journal of the European Academy of Dermatology and Venereology. 34 (2020) 10 - p. , 2020

Link: https://doi.org/10.1111/..

5

生物药物 ixekizumab 和 guselkumab 治疗中度至重度斑块型银屑病的比较研究:

Blauvelt, A. ; Papp, K. ; Gottlieb, A....
British Journal of Dermatology. 182 (2020) 6 - p. , 2020

Link: https://doi.org/10.1111/..

6

Corrigendum: Systematic review on rapidity of onset of acti..:

Egeberg, A. ; Andersen, Y.M.F. ; Halling‐Overgaard, A.‐S....
Journal of the European Academy of Dermatology and Venereology. 34 (2020) 9 - p. 2156-2156 , 2020

Link: https://doi.org/10.1111/..

7

A head‐to‐head comparison of ixekizumab vs. guselkumab in p..:

Blauvelt, A. ; Papp, K. ; Gottlieb, A....
British Journal of Dermatology. 182 (2020) 6 - p. 1348-1358 , 2020

Link: https://doi.org/10.1111/..

8

A study comparing the biologic drugs ixekizumab and guselku..:

Blauvelt, A. ; Papp, K. ; Gottlieb, A....
British Journal of Dermatology. 182 (2020) 6 - p. , 2020

Link: https://doi.org/10.1111/..

9

A head‐to‐head comparison of ixekizumab vs. guselkumab in p..:

Blauvelt, A. ; Leonardi, C. ; Elewski, B....
British Journal of Dermatology. 184 (2020) 6 - p. 1047-1058 , 2020

Link: https://doi.org/10.1111/..

10

Comorbidities of alopecia areata: a population‐based cohort..:

Egeberg, A. ; Anderson, S. ; Edson‐Heredia, E..
Clinical and Experimental Dermatology. 46 (2020) 4 - p. 651-656 , 2020

Link: https://doi.org/10.1111/..

11

Ixekizumab improves secondary lesional signs, pain and sexu..:

Merola, J.F. ; Ghislain, P.‐D. ; Dauendorffer, J.N....
Journal of the European Academy of Dermatology and Venereology. 34 (2020) 6 - p. 1257-1262 , 2020

Link: https://doi.org/10.1111/..

12

Systematic review on rapidity of onset of action for interl..:

Egeberg, A. ; Andersen, Y.M.F. ; Halling‐Overgaard, A.‐S....
Journal of the European Academy of Dermatology and Venereology. 34 (2019) 1 - p. 39-46 , 2019

Link: https://doi.org/10.1111/..

13

Plaque psoriasis in patients with palmoplantar pustulosis:

Andersen, Y.M.F. ; Augustin, M. ; Petersen, J....
British Journal of Dermatology. 181 (2019) 5 - p. , 2019

Link: https://doi.org/10.1111/..

14

Characteristics and prevalence of plaque psoriasis in patie..:

Andersen, Y.M.F. ; Augustin, M. ; Petersen, J....
British Journal of Dermatology. 181 (2019) 5 - p. 976-982 , 2019

Link: https://doi.org/10.1111/..

15

PSY6 HUMANISTIC AND ECONOMIC BURDEN OF DISEASE FOR PSORIASI..:

Papadimitropoulos, M. ; Romiti, R. ; Vorstenbosch, E.C.W....
Value in Health Regional Issues. 19 (2019) - p. S81 , 2019

Link: https://doi.org/10.1016/..